Autonomix Medical Granted Canadian Patent for Nerve-Targeted Treatments

Autonomix Medical, Inc. announced it has been granted Canadian Patent No. 3,158,197, titled "Endoscopic Sympathectomy Systems and Methods." This new patent strengthens the company's intellectual property position in nerve-targeted therapies and denervation applications, bringing its global IP portfolio to 112 issued or pending patent applications. The patented technology focuses on real-time nerve monitoring, diagnostic evaluation, and feedback-guided neuromodulation for precise targeting of autonomic nerves in chronic disease states, reinforcing Autonomix's competitive edge in major commercial markets.